Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,972 | 167 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $588.23 | 22 | $0 (2020) |
| Merck Sharp & Dohme LLC | $475.77 | 17 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $305.73 | 13 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $277.52 | 19 | $0 (2019) |
| Novo Nordisk Inc | $247.74 | 19 | $0 (2020) |
| ViiV Healthcare Company | $233.85 | 7 | $0 (2022) |
| Amgen Inc. | $194.09 | 7 | $0 (2023) |
| Amarin Pharma Inc. | $173.95 | 4 | $0 (2020) |
| AbbVie Inc. | $172.77 | 4 | $0 (2021) |
| Gilead Sciences, Inc. | $151.10 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $105.24 | 1 | Amgen Inc. ($105.24) |
| 2022 | $364.62 | 3 | Fresenius USA Marketing, Inc. ($142.19) |
| 2021 | $281.04 | 3 | Horizon Therapeutics plc ($131.87) |
| 2020 | $287.80 | 17 | ViiV Healthcare Company ($59.15) |
| 2019 | $1,273 | 71 | Merck Sharp & Dohme Corporation ($192.33) |
| 2018 | $1,025 | 50 | PFIZER INC. ($315.66) |
| 2017 | $635.82 | 22 | PFIZER INC. ($163.92) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/16/2023 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $105.24 | General |
| Category: Bone Health | ||||||
| 07/13/2022 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $122.43 | General |
| Category: HIV | ||||||
| 06/15/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $142.19 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/06/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $131.87 | General |
| Category: KRYSTEXXA | ||||||
| 06/30/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $121.35 | General |
| Category: Neuroscience | ||||||
| 03/10/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardiovascular | ||||||
| 03/09/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 03/03/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: HIV | ||||||
| 03/03/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/26/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.54 | General |
| 02/18/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardiovascular | ||||||
| 02/17/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/10/2020 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: VACCINES | ||||||
| 02/04/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Respiratory | ||||||
| 02/04/2020 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 01/31/2020 | ViiV Healthcare Company | DOVATO (Drug), JULUCA, TIVICAY | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: HIV | ||||||
| 01/21/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: HIV | ||||||
| 01/14/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/07/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.15 | General |
| 01/02/2020 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes Care | ||||||
| 12/20/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Hypertriglyceridemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 574 | 737 | $85,247 | $42,364 |
| 2022 | 3 | 89 | 98 | $8,033 | $4,679 |
| 2020 | 2 | 30 | 34 | $8,069 | $985.31 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 203 | $31,262 | $16,175 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $13,260 | $7,938 | 59.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 71 | $6,958 | $3,942 | 56.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $8,160 | $3,211 | 39.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 36 | 37 | $8,917 | $2,871 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 24 | $5,376 | $2,702 | 50.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $5,185 | $2,460 | 47.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 20 | 21 | $1,953 | $1,049 | 53.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 119 | 192 | $960.00 | $935.90 | 97.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 27 | 27 | $1,566 | $467.37 | 29.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $671.00 | $320.87 | 47.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 24 | $576.00 | $228.48 | 39.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 13 | 13 | $403.00 | $61.90 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 46 | $7,084 | $4,334 | 61.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 13 | 13 | $754.00 | $230.10 | 30.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 33 | 39 | $195.00 | $114.66 | 58.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 21 | $7,770 | $947.09 | 12.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 12 | 13 | $299.00 | $38.22 | 12.8% |
About Dr. Brian Ross, MD
Dr. Brian Ross, MD is a Family Medicine healthcare provider based in Hickory, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2013. The National Provider Identifier (NPI) number assigned to this provider is 1114366317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Ross, MD has received a total of $3,972 in payments from pharmaceutical and medical device companies, with $105.24 received in 2023. These payments were reported across 167 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,972).
As a Medicare-enrolled provider, Ross has provided services to 693 Medicare beneficiaries, totaling 869 services with total Medicare billing of $48,028. Data is available for 3 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Hickory, NC
- Active Since 06/20/2013
- Last Updated 09/30/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1114366317
Products in Payments
- FARXIGA (Drug) $232.30
- Vascepa (Drug) $173.95
- CHANTIX (Drug) $171.31
- TOUJEO (Drug) $156.41
- Androgel (Drug) $144.95
- Velphoro (Drug) $142.19
- Ozempic (Drug) $135.40
- Prolia (Biological) $134.18
- KRYSTEXXA (Biological) $131.87
- ZEPATIER (Drug) $125.00
- MYRBETRIQ (Drug) $123.07
- APRETUDE (Biological) $122.43
- EUCRISA (Drug) $122.23
- ZEPOSIA (Drug) $121.35
- DOVATO (Drug) $111.42
- STEGLATRO (Drug) $100.02
- ZERBAXA (Drug) $100.00
- PREVNAR - 13 (Biological) $98.78
- TRUMENBA (Biological) $98.76
- JANUVIA (Drug) $93.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hickory
Jonathan Wilson, Do, DO
Family Medicine — Payments: $31,125
Dr. Michael Desantis, M.d, M.D
Family Medicine — Payments: $12,291
David Duralia, M.d, M.D
Family Medicine — Payments: $11,991
Dr. Mary Britton, M.d, M.D
Family Medicine — Payments: $8,725
Robert Lee, Md, MD
Family Medicine — Payments: $8,629
Dr. Gregory Brooks, Md, MD
Family Medicine — Payments: $8,580